Jean Bousquet to Severity of Illness Index
This is a "connection" page, showing publications Jean Bousquet has written about Severity of Illness Index.
Connection Strength
0.130
-
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19. Int Arch Allergy Immunol. 2021; 182(4):324-338.
Score: 0.030
-
Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma. Respir Med. 2019 04; 150:51-62.
Score: 0.026
-
Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy. 2017 Oct; 72(10):1475-1484.
Score: 0.023
-
Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study. BMC Pulm Med. 2017 Apr 28; 17(1):75.
Score: 0.023
-
Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study. Int Arch Allergy Immunol. 2010; 153(4):395-402.
Score: 0.014
-
Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1752-1755.e3.
Score: 0.006
-
The sensitization pattern differs according to rhinitis and asthma multimorbidity in adults: the EGEA study. Clin Exp Allergy. 2017 Apr; 47(4):520-529.
Score: 0.006